Enanta Pharmaceuticals In... (ENTA)
NASDAQ: ENTA
· Real-Time Price · USD
8.19
0.19 (2.37%)
At close: Aug 18, 2025, 3:59 PM
8.44
3.05%
After-hours: Aug 18, 2025, 07:44 PM EDT
Enanta Pharmaceuticals Revenue
Enanta Pharmaceuticals reported an annual revenue of $67.64M, reflecting a -14.61% growth. For the quarter ending June 30, 2025, Enanta Pharmaceuticals generated $18.31M in revenue.
Revenue (ttm)
67.64M
Revenue Growth
-14.61%
Price / Sales Ratio
3.24
Revenue / Employee
516.3K
Employees
131
Market Cap
175.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Sep 30, 2024 | 67.64M | -14.61% |
| Sep 30, 2023 | 79.2M | -8.07% |
| Sep 30, 2022 | 86.16M | -11.24% |
| Sep 30, 2021 | 97.07M | -20.74% |
| Sep 30, 2020 | 122.47M | -40.31% |
| Sep 30, 2019 | 205.2M | -0.69% |
| Sep 30, 2018 | 206.63M | +100.97% |
| Sep 30, 2017 | 102.81M | +16.48% |
| Sep 30, 2016 | 88.27M | -45.13% |
| Sep 30, 2015 | 160.88M | +236.98% |
| Sep 30, 2014 | 47.74M | +48.94% |
| Sep 30, 2013 | 32.05M | -23.15% |
| Sep 30, 2012 | 41.71M | -0.42% |
| Sep 30, 2011 | 41.88M | +83.99% |
| Sep 30, 2010 | 22.76M | n/a |